BROOKDALE SENIOR LIVING INC (BKD) Stock Fundamental Analysis
NYSE:BKD - New York Stock Exchange, Inc. - US1124631045 - Common Stock - Currency: USD
Overall BKD gets a fundamental rating of 2 out of 10. We evaluated BKD against 102 industry peers in the Health Care Providers & Services industry. BKD may be in some trouble as it scores bad on both profitability and health. BKD does not seem to be growing, but still is valued expensively.
1. Profitability
1.1 Basic Checks
In the past year BKD has reported negative net income.
BKD had a positive operating cash flow in the past year.
In the past 5 years BKD reported 4 times negative net income.
Of the past 5 years BKD 4 years had a positive operating cash flow.
1.2 Ratios
Looking at the Return On Assets, with a value of -3.82%, BKD is doing worse than 63.73% of the companies in the same industry.
BKD's Return On Equity of -161.77% is on the low side compared to the rest of the industry. BKD is outperformed by 77.45% of its industry peers.
BKD's Return On Invested Capital of 0.92% is in line compared to the rest of the industry. BKD outperforms 42.16% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | -3.82% | ||
| ROE | -161.77% | ||
| ROIC | 0.92% |
ROA(3y)-3.53%
ROA(5y)-2.19%
ROE(3y)-60.92%
ROE(5y)-37.35%
ROIC(3y)N/A
ROIC(5y)N/A
1.3 Margins
BKD has a Operating Margin (2.07%) which is in line with its industry peers.
In the last couple of years the Operating Margin of BKD has grown nicely.
BKD has a Gross Margin (25.92%) which is in line with its industry peers.
BKD's Gross Margin has improved in the last couple of years.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| OM | 2.07% | ||
| PM (TTM) | N/A | ||
| GM | 25.92% |
OM growth 3YN/A
OM growth 5Y54.21%
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y12.08%
GM growth 5Y3.43%
2. Health
2.1 Basic Checks
With a Return on Invested Capital (ROIC) below the Cost of Capital (WACC), BKD is destroying value.
BKD has more shares outstanding than it did 1 year ago.
BKD has more shares outstanding than it did 5 years ago.
Compared to 1 year ago, BKD has an improved debt to assets ratio.
2.2 Solvency
BKD has an Altman-Z score of -0.24. This is a bad value and indicates that BKD is not financially healthy and even has some risk of bankruptcy.
BKD has a Altman-Z score of -0.24. This is in the lower half of the industry: BKD underperforms 78.43% of its industry peers.
A Debt/Equity ratio of 29.13 is on the high side and indicates that BKD has dependencies on debt financing.
BKD has a Debt to Equity ratio of 29.13. This is amonst the worse of the industry: BKD underperforms 85.29% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 29.13 | ||
| Debt/FCF | N/A | ||
| Altman-Z | -0.24 |
ROIC/WACC0.12
WACC7.8%
2.3 Liquidity
A Current Ratio of 0.82 indicates that BKD may have some problems paying its short term obligations.
BKD has a worse Current ratio (0.82) than 78.43% of its industry peers.
A Quick Ratio of 0.82 indicates that BKD may have some problems paying its short term obligations.
With a Quick ratio value of 0.82, BKD is not doing good in the industry: 71.57% of the companies in the same industry are doing better.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Current Ratio | 0.82 | ||
| Quick Ratio | 0.82 |
3. Growth
3.1 Past
BKD shows a strong negative growth in Earnings Per Share. In the last year the EPS decreased by -35.06%.
BKD shows a small growth in Revenue. In the last year, the Revenue has grown by 3.65%.
Measured over the past years, BKD shows a decrease in Revenue. The Revenue has been decreasing by -5.08% on average per year.
EPS 1Y (TTM)-35.06%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-115.38%
Revenue 1Y (TTM)3.65%
Revenue growth 3Y4.25%
Revenue growth 5Y-5.08%
Sales Q2Q%3.96%
3.2 Future
The Earnings Per Share is expected to grow by 17.30% on average over the next years. This is quite good.
BKD is expected to show a small growth in Revenue. In the coming years, the Revenue will grow by 1.26% yearly.
EPS Next Y29.64%
EPS Next 2Y22.04%
EPS Next 3Y17.3%
EPS Next 5YN/A
Revenue Next Year2.28%
Revenue Next 2Y-0.67%
Revenue Next 3Y1.26%
Revenue Next 5YN/A
3.3 Evolution
When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
4. Valuation
4.1 Price/Earnings Ratio
BKD reported negative earnings for the last year, which makes the Price/Earnings Ratio negative.
Besides the negative Price/Earnings Ratio, also the Forward Price/Earnings Ratio is negative for BKD. No positive earnings are expected for the next year.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | N/A | ||
| Fwd PE | N/A |
4.2 Price Multiples
The rest of the industry has a similar Enterprise Value to EBITDA ratio as BKD.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| P/FCF | N/A | ||
| EV/EBITDA | 13.12 |
4.3 Compensation for Growth
A more expensive valuation may be justified as BKD's earnings are expected to grow with 17.30% in the coming years.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y22.04%
EPS Next 3Y17.3%
5. Dividend
5.1 Amount
BKD does not give a dividend.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | N/A |
6.95
-0.15 (-2.11%)
Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Providers & Services
Earnings (Last)
Earnings (Next)
Inst Owners106.89%
Inst Owner Change6.68%
Ins Owners3.68%
Ins Owner Change0.06%
Market Cap1.63B
Analysts72
Price Target7.4 (6.47%)
Short Float %3.56%
Short Ratio2.48
Dividend
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | N/A |
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)0
Avg EPS beat(2)-109.89%
Min EPS beat(2)-145.33%
Max EPS beat(2)-74.45%
EPS beat(4)0
Avg EPS beat(4)-64.42%
Min EPS beat(4)-145.33%
Max EPS beat(4)-12.21%
EPS beat(8)2
Avg EPS beat(8)-28.12%
EPS beat(12)4
Avg EPS beat(12)-12.37%
EPS beat(16)7
Avg EPS beat(16)8.7%
Revenue beat(2)0
Avg Revenue beat(2)-1.23%
Min Revenue beat(2)-1.36%
Max Revenue beat(2)-1.1%
Revenue beat(4)0
Avg Revenue beat(4)-1.16%
Min Revenue beat(4)-1.36%
Max Revenue beat(4)-1%
Revenue beat(8)0
Avg Revenue beat(8)-0.94%
Revenue beat(12)0
Avg Revenue beat(12)-0.82%
Revenue beat(16)0
Avg Revenue beat(16)-1.14%
PT rev (1m)3.57%
PT rev (3m)5.07%
EPS NQ rev (1m)-9.09%
EPS NQ rev (3m)-6.67%
EPS NY rev (1m)-10.71%
EPS NY rev (3m)2.1%
Revenue NQ rev (1m)0.03%
Revenue NQ rev (3m)0.28%
Revenue NY rev (1m)-0.12%
Revenue NY rev (3m)-0.52%
Valuation
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | N/A | ||
| Fwd PE | N/A | ||
| P/S | 0.52 | ||
| P/FCF | N/A | ||
| P/OCF | 8.54 | ||
| P/B | 11.1 | ||
| P/tB | 13.64 | ||
| EV/EBITDA | 13.12 |
EPS(TTM)-1.04
EYN/A
EPS(NY)-0.45
Fwd EYN/A
FCF(TTM)-1.82
FCFYN/A
OCF(TTM)0.81
OCFY11.71%
SpS13.47
BVpS0.63
TBVpS0.51
PEG (NY)N/A
PEG (5Y)N/A
Profitability
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | -3.82% | ||
| ROE | -161.77% | ||
| ROCE | 1.16% | ||
| ROIC | 0.92% | ||
| ROICexc | 0.96% | ||
| ROICexgc | 0.96% | ||
| OM | 2.07% | ||
| PM (TTM) | N/A | ||
| GM | 25.92% | ||
| FCFM | N/A |
ROA(3y)-3.53%
ROA(5y)-2.19%
ROE(3y)-60.92%
ROE(5y)-37.35%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5Y47.69%
ROICexc growth 3YN/A
ROICexc growth 5Y48.52%
OM growth 3YN/A
OM growth 5Y54.21%
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y12.08%
GM growth 5Y3.43%
F-Score4
Asset Turnover0.51
Health
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 29.13 | ||
| Debt/FCF | N/A | ||
| Debt/EBITDA | 9.73 | ||
| Cap/Depr | 165.39% | ||
| Cap/Sales | 19.58% | ||
| Interest Coverage | 0.27 | ||
| Cash Conversion | 43.42% | ||
| Profit Quality | N/A | ||
| Current Ratio | 0.82 | ||
| Quick Ratio | 0.82 | ||
| Altman-Z | -0.24 |
F-Score4
WACC7.8%
ROIC/WACC0.12
Cap/Depr(3y)69.44%
Cap/Depr(5y)87.89%
Cap/Sales(3y)8.28%
Cap/Sales(5y)9.97%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-35.06%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-115.38%
EPS Next Y29.64%
EPS Next 2Y22.04%
EPS Next 3Y17.3%
EPS Next 5YN/A
Revenue 1Y (TTM)3.65%
Revenue growth 3Y4.25%
Revenue growth 5Y-5.08%
Sales Q2Q%3.96%
Revenue Next Year2.28%
Revenue Next 2Y-0.67%
Revenue Next 3Y1.26%
Revenue Next 5YN/A
EBIT growth 1Y82.52%
EBIT growth 3YN/A
EBIT growth 5Y46.37%
EBIT Next Year528.24%
EBIT Next 3Y95.37%
EBIT Next 5YN/A
FCF growth 1Y-163.82%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y276.93%
OCF growth 3YN/A
OCF growth 5Y-5.14%